Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology Spain Optimizing Clinical Care Delivery for Patients with Multiple Myeloma Receiving Bispecific AntibodiesRelease Date:Quality Improvement Oncology All Enhancing HCP Education in Maternal VaccinationRelease Date:Education Vaccines Saudi Arabia Diagnosis and Treatment of Cancer CachexiaRelease Date:Education Oncology All Evidence-Based Education on the Potential Impact of a Generic JAK Inhibitor on the Management of Rheumatologic DiseasesRelease Date:Education Inflammation & Immunology USA B-cell Maturation Antigen (BCMA) Bi-Specific Antibodies (BsAbs) in Relapsed/Refractory Multiple Myeloma (RRMM)Release Date:Education Oncology USA Education on Mechanism of Action of JAK3 and TEC Family Kinase Role in Alopecia AreataRelease Date:Education Inflammation & Immunology USA 2026 Hemophilia Fellowship – United StatesRelease Date:Fellowship Rare Disease All Pediatric Pneumococcal Disease and Serotype Distribution: Surveillance Studies in Saudi ArabiaRelease Date:Research Vaccines Saudi Arabia Optimising Ulcerative Colitis Care: Bridging Knowledge Gaps, Integrating Biomarker-Based Strategies, and Advancing EquityRelease Date:Education Inflammation & Immunology Australia Surveillance of Pneumococcal Disease Serotype Distribution in Pediatric and Adult Pneumococcal Disease in TürkiyeRelease Date:Research Vaccines Turkey Surveillance of Pneumococcal Disease Serotype Distribution in Pediatric and Adult Pneumococcal Disease in TürkiyeRelease Date:Research Vaccines Turkey Title Grant Type Focus Area Country Application Due Date 2023 Inflammatory Bowel Disease (IBD) FellowshipRelease Date:Fellowship Inflammation & Immunology USA Advances in the Management of Ulcerative Colitis (UC)Release Date:Education Inflammation & Immunology USA Knowledge Gaps in Managing High-Risk Patients and COVID-19Release Date:Education Hospital USA 2023 Bladder Cancer Canada-EMD Serono-Pfizer Quality Improvement Request for ProposalsRelease Date:Partner: Bladder Cancer Canada; EMD SeronoQuality Improvement Oncology Canada Relapsed/Refractory Multiple Myeloma (North America and Europe)Release Date:Education Oncology All Improving Metastatic Breast Cancer (mBC) Quality of Care and Equity in Latin AmericaRelease Date:Partner: Conquer Cancer, the ASCO FoundationQuality Improvement Oncology All Junior Investigator Global ATTR Amyloidosis Research ASPIRE (All countries except for the United States)Release Date:Research Rare Disease All Call for Independent Medical Education Grant Applications Oncology – Prostate CancerEducation Oncology USA Improving the Care of Patients Living with Metastatic Breast Cancer (mBC)Release Date:Partner: Rethink Breast CancerQuality Improvement Oncology Canada REI: Advisory Group for Patient-Reported Outcome Implementation in Vulnerable and Underserved PopulationsQuality Improvement Oncology USA Improving the quality of care of patients with urothelial cancerQuality Improvement Oncology Italy Mental Health in RheumatologyRelease Date:Quality Improvement Inflammation & Immunology Canada